Jiangsu Simcere Pharmaceutical Co., Ltd.

This early-stage trial tested a new drug called SIM0501, both alone and combined with an existing cancer drug (olaparib), in people with advanced solid tumors that had specific genetic changes. The main goal was to check the safety, side effects, and how the drug moves through th…